Royan Institute
Iran
- Country
- Iran
- Ownership
- Private
- Established
- 1991-01-01
- Employees
- -
- Market Cap
- -
Intra-ovarian Injection of MSC-EVs in Idiopathic Premature Ovarian Failure
Phase 1
Recruiting
- Conditions
- Premature Ovarian Failure
- Interventions
- Biological: Intra-ovarian injection of bone marrow mesenchymal stromal cells-derived extracellular vesicles
- First Posted Date
- 2024-01-11
- Last Posted Date
- 2024-01-11
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 10
- Registration Number
- NCT06202547
- Locations
- 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of
Dual Ovarian Stimulation (Duostim) and Shanghai Protocols in Poor Ovarian Responders
Phase 3
Completed
- Conditions
- Assisted Reproductive Techniques
- Interventions
- Other: Doustim protocol
- First Posted Date
- 2024-01-10
- Last Posted Date
- 2024-01-10
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 116
- Registration Number
- NCT06199960
- Locations
- 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of
Cinnamon and COH in PCOS Women Underdoing IVF/ICSI Cycles
Not Applicable
Recruiting
- Conditions
- Polycystic Ovary Syndrome
- Interventions
- Dietary Supplement: Oral cinnamon supplementation
- First Posted Date
- 2024-01-10
- Last Posted Date
- 2024-01-10
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 80
- Registration Number
- NCT06199024
- Locations
- 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of
NAC Effect on Infertile Women With Endometrioma
Phase 3
- Conditions
- Female InfertilityEndometriomaStress Oxidative
- Interventions
- Drug: placebo
- First Posted Date
- 2022-07-15
- Last Posted Date
- 2022-07-15
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 140
- Registration Number
- NCT05460858
- Locations
- 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of
Nk Cell Therapy for Recurrent Glioblastoma Multiform Patients
Phase 1
- Conditions
- Glioblastoma MultiformRecurrent Glioblastoma
- Interventions
- Biological: NK cell therapy
- First Posted Date
- 2021-11-04
- Last Posted Date
- 2021-11-22
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 5
- Registration Number
- NCT05108012
- Locations
- 🇮🇷
Royan institute, Tehran, Iran, Islamic Republic of
Intramuscular Injection of Human Chorionic Gonadotropin in Frozen Embryo Transfer Cycles
Not Applicable
Completed
- Conditions
- Embryo Implantation
- Interventions
- Drug: The effect of intramuscular injection of triple doses of human chorionic gonadotropin in frozen embryo transfer cycles
- First Posted Date
- 2021-04-22
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 200
- Registration Number
- NCT04855383
- Locations
- 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of
L-carnitine and COH in PCOS Women Undergoing IVF/ICSI Cycles
- First Posted Date
- 2020-12-17
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 110
- Registration Number
- NCT04672720
- Locations
- 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of
Repeated Doses of GnRH Agonist as Oocyte Triggering in Antagonist Protocol for Patients With Polycystic Ovary Syndrome
Not Applicable
Completed
- Conditions
- Polycystic Ovary Syndrome
- Interventions
- Other: Repeated dose of GnRH agonist
- First Posted Date
- 2020-10-23
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 70
- Registration Number
- NCT04600986
- Locations
- 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of
The Effect of Dual Trigger for Final Oocyte Maturation on IVF/ICSI Outcomes in Patients With Suboptimal Ovarian Response
Not Applicable
Completed
- Conditions
- Ovarian StimulationReproductive Techniques, Assisted
- Interventions
- Other: Dual triggering
- First Posted Date
- 2020-09-16
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 52
- Registration Number
- NCT04549649
- Locations
- 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of
Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome
Phase 2
- Conditions
- Covid-19
- Interventions
- Biological: Cell therapy protocol 2Biological: Cell therapy protocol 1
- First Posted Date
- 2020-04-28
- Last Posted Date
- 2020-04-30
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 60
- Registration Number
- NCT04366063
- Locations
- 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of
© Copyright 2025. All Rights Reserved by MedPath